semaglutide macon ga FBI warns about counterfeit weight loss drugs Use of new diet drugs

The STEP 1 trial (Wilding et al., 2021, NEJM) evaluated Semaglutide 2.4mg in participants without diabetes and demonstrated a mean body weight reduction of 14.9% from baseline over 68 weeks

This led to the approval of the first GLP-1RA for the treatment of obesity in 2014

Products sold online as natural Ozempic, weight loss patches, or fat-burning supplements are not approved medications and arent a substitute for medical weight loss management

Semaglutide, a GLP-1 receptor agonist, has been shown to significantly support weight loss by enhancing satiety and reducing appetite, while also improving glycemic control

For those exploring the transition between these medications, the semaglutide to tirzepatide conversion chart maps equivalent doses